This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Steven Douglas Hiscock
Introduction
Steven Douglas Hiscock is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of chemistry, particularly in the development of compounds that have therapeutic applications. His work focuses on creating innovative solutions for medical challenges.
Latest Patents
Hiscock holds a patent for chemical compounds that are Factor Xa inhibitors. These compounds are useful in the treatment of thrombotic disorders, showcasing his commitment to advancing medical science. The patent details compounds of formula (I) in which R, R, and R have specific meanings as outlined in the specification.
Career Highlights
Steven is currently associated with Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create impactful medical solutions. His work has the potential to improve patient outcomes in various therapeutic areas.
Collaborations
Hiscock has collaborated with esteemed colleagues such as Stuart Donald Jones and Daniel Jon Sall. These partnerships enhance the innovation process and contribute to the successful development of new therapeutic compounds.
Conclusion
Steven Douglas Hiscock exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in addressing medical needs. His work continues to pave the way for advancements in treatment options for thrombotic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile